Comparable Performance of the Kansas City Cardiomyopathy Questionnaire in Patients With Heart Failure With Preserved and Reduced Ejection Fraction-Reference-Cited by-同舟云学术

Comparable Performance of the Kansas City Cardiomyopathy Questionnaire in Patients With Heart Failure With Preserved and Reduced Ejection Fraction

Published:2013-11 Issue:6 Volume:6 Page:1139-1146
ISSN:1941-3289
Container-title:Circulation: Heart Failure
language:en
Short-container-title:Circ Heart Fail

Author:

Joseph Susan M.¹,Novak Eric¹,Arnold Suzanne V.¹,Jones Philip G.¹,Khattak Himad¹,Platts Anne E.¹,Dávila-Román Victor G.¹,Mann Douglas L.¹,Spertus John A.¹

Affiliation:

1. From the Cardiovascular Division, Department of Medicine, Washington University School of Medicine, St Louis, MO (S.M.J., E.N., H.K., A.E.P., V.G.D.-R., D.L.M.); and Saint Luke’s Mid-America Heart Institute, University of Missouri, Kansas City (S.V.A., P.G.J., J.A.S.).

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine

Reference45 articles.

1. Trends in Prevalence and Outcome of Heart Failure with Preserved Ejection Fraction

2. The treatment of heart failure with preserved ejection fraction (“diastolic heart failure”)

3. Heart failure with preserved left ventricular systolic function

4. Interpreting patient-reported outcome results: US FDA guidance and emerging methods

5. FDA guidance on patient reported outcomes

Cited by 125 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of Semaglutide on Symptoms, Function, and Quality of Life in Patients With Heart Failure With Preserved Ejection Fraction and Obesity: A Prespecified Analysis of the STEP-HFpEF Trial;Circulation;2024-01-16

2. New York Heart Association Class and Kansas City Cardiomyopathy Questionnaire in Acute Heart Failure;JAMA Network Open;2023-10-24

3. Changing health related quality of life and outcomes in heart failure by age, sex and subtype;eClinicalMedicine;2023-10

4. High-Intensity Small Muscle Mass Training in Patients With Heart Failure: Rationale and Design of a Randomized Controlled Trial;Physical Therapy;2023-09-27

5. Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity;New England Journal of Medicine;2023-09-21